Topics

Cyclo Therapeutics Prepares for Alzheimer's Development Program After Success with First Patient

07:08 EDT 28 Oct 2019 | FinanzNachrichten

ORLANDO, FL / ACCESSWIRE / October 28, 2019 / Cyclo Therapeutics (OTCQB:CTDH), formerly CTD Holdings, is moving forward on the development of an Alzheimer's treatment using its proprietary Trappsol...

Original Article: Cyclo Therapeutics Prepares for Alzheimer's Development Program After Success with First Patient

NEXT ARTICLE

More From BioPortfolio on "Cyclo Therapeutics Prepares for Alzheimer's Development Program After Success with First Patient"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...